Related Experiment Video
Updated: Jan 15, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges
Nicholas W S Chew1,2, Anurag Mehta3, Rachel Goh4
1Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore. nicholas_ws_chew@nuhs.edu.sg.
Insights
Cardiovascular-liver-metabolic diseases, including fatty liver disease, diabetes, and obesity, form a syndemic. A new framework proposes multisystem interventions to address these interconnected public health challenges.
Area of Science:
- Public Health
- Epidemiology
- Metabolic Diseases
Background:
- Metabolic-dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease (CVD) are escalating global epidemics.
- These conditions often coexist, forming a cardiovascular-liver-metabolic (CLM) syndemic with shared underlying mechanisms and socioeconomic drivers.
Purpose of the Study:
- To establish a unified framework for understanding and addressing the CLM syndemic.
- To present epidemiological data on the current burden and future trends of CLM diseases.
- To discuss challenges and propose integrated solutions for CLM health promotion.
Main Methods:
- Review of epidemiological data to illustrate disease burden and trends.
- Development of a micro-meso-macro framework for CLM health interventions.
- Analysis of socioeconomic influences and competing risks within the CLM construct.
Main Results:
- The CLM syndemic presents a significant and growing public health challenge.
- A proposed micro-meso-macro framework integrates strategies from individual risk prediction to macro-level social determinants.
- Multisystem interventions are necessary to simultaneously address the interconnected CLM disease epidemics.
Conclusions:
- Addressing the CLM syndemic requires a comprehensive, multi-level approach.
- Integrating precision prevention, community-based health promotion, and systemic interventions is crucial.
- Tackling inequities in social and commercial determinants of health is essential for effective CLM disease control.
Abstract:
The growing epidemics of metabolic-dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, obesity and cardiovascular disease are inextricably linked. Cardiovascular-liver-metabolic (CLM) diseases coexist and interact to constitute a synergy of epidemics (a syndemic), with shared mechanisms and socioeconomic influences. The goal of this Review is to construct this complex public-health issue into a unified framework, using epidemiological data to illustrate the current burden of disease and the trends in the CLM syndemic and to make projections for the future. We also discuss the challenges of promoting CLM health and the need for shared solutions. The proposed micro-meso-macro framework integrates strategies to improve risk prediction and precision prevention and to disentangle the competing risks within the CLM construct (micro), while keeping communities at the heart of CLM health promotion by ensuring access to healthy foods, healthy environments and metabolic interventions (meso). In addition, we propose interventions to eliminate inequities in the social and commercial determinants of health, from communities to healthcare systems (macro). Thus, multisystem interventions could address the trajectories of the CLM disease epidemics simultaneously.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

